What does this research mean for the field?

Mavacoxib is a strong pharmacological candidate for providing extended-duration analgesia in sheep to address the prolonged pain and inflammation associated with routine husbandry procedures. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

What question did this study set out to answer?

To evaluate the pharmacological rationale, limitations of current analgesics, and potential role of the selective COX-2 inhibitor mavacoxib for extended pain relief following sheep husbandry procedures.

September 8, 2026AnimalsOpen Access

The Potential of Selective COX-2 Inhibitor Mavacoxib for Extended Analgesia in Sheep Husbandry

View Full Paper

Ask AI

Bookmark

Authors

OFOliver Fioretto LMLee Metcalf SLSabrina LomaxThe University of Sydney

Discussion

Member takes

Implication

Narrative review highlights mavacoxib for extended analgesia in sheep, suggesting its long half-life could better match prolonged post-procedural pain in extensive grazing systems.

Key Points

To evaluate the pharmacological rationale, limitations of current analgesics, and potential role of the selective COX-2 inhibitor mavacoxib for extended pain relief following sheep husbandry procedures.
Reviewed physiological and behavioral markers of pain and inflammation associated with routine husbandry interventions in sheep.
Evaluated the pharmacodynamics and pharmacokinetics of mavacoxib, drawing on its established two-week half-life in canines to assess suitability for ovine pain management.
Commercially available veterinary analgesics have a duration of action that is consistently shorter than the prolonged pain and inflammatory responses triggered by routine husbandry.
Mavacoxib demonstrates pharmacological potential to provide long-duration analgesia that aligns with the multiday post-procedural healing phase.
Ovine-specific pharmacokinetic, safety, and efficacy data are currently lacking and required before practical deployment in extensive grazing systems.

Cite This Study

Fioretto et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd79b58e84d0ff5b46755 https://doi.org/10.3390/ani16172791

View Full Paper

Ask AI

Bookmark

Implication

Narrative review highlights mavacoxib for extended analgesia in sheep, suggesting its long half-life could better match prolonged post-procedural pain in extensive grazing systems.

The Potential of Selective COX-2 Inhibitor Mavacoxib for Extended Analgesia in Sheep Husbandry

Discussion

Member takes

Implication

Key Points

Cite This Study

The Potential of Selective COX-2 Inhibitor Mavacoxib for Extended Analgesia in Sheep Husbandry

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider